Recently diagnosed with HIV? Click here

HIV Media Digest 16 Apr

Newsletter • 16 April 2012

A roundup of HIV-related news from Australian and selected international media.

In this edition:

Our Region

Family vital in HIV/AIDS fight

Fiji Times (Fiji), 14 Apr

PRESIDENT Ratu Epeli Nailatikau stressed the significance of preventing sexual transmitted diseases such as HIV/AIDS while speaking at the University of Fiji graduation ceremony yesterday.

family social support Fiji HIV

HIV Treatment and Care

Engineering CD8 Cells to Kill HIV in Tissues

AIDSMeds (US), 13 Apr

Expanding on previous research providing proof-of-concept that human stem cells can be genetically engineered into HIV-fighting cells, researchers at the University of California at Los Angeles (UCLA) have now demonstrated that these cells can actually attack HIV-infected cells in a living organism.

genetic engineering CD8 stem cells treatments HIV

Welfare & Work

No charge for mailed Centrelink statements

WA Today, 16 Apr

Centrelink will not charge people for sending them statements, its minister says. The welfare agency is trying to cut its paper use and will largely stop using letter post from July.

Kim Carr Centrelink

Sexual Health

WA Premier rejects Browse Gas fears

WA Today, 13 Apr

Woodside Energy has vowed to manage the potential social impacts to Broome and Aboriginal communities if the Browse liquified natural gas hub does proceed at James Price Point bringing with it a construction force of about 6000 workers.

Broome Colin Barnett drugs fly-in-fly-out mining industry Western Australia sex work and sex workers STIs

Drugs

Demand drives needle exchange need

ABC News, 13 Apr

An outreach group says increasing demand from Bunbury drug users has led it to open the region's first permanent needle and syringe exchange.

HIV WASUA Western Australia needle exchange

Hepatitis

Silent epidemic calls out for cure

Sydney Morning Herald, 15 Apr

WHEN healthcare worker Kerri-Anne Smith started feeling constantly exhausted, she put it down to being a single mother raising four children while working and studying.

Stuart Loveday Hepatitis NSW HCV treatments telaprevir personal stories HCV

Gilead hepatitis C data to show if deal paid off

San Francisco Chronicle (US), 13 Apr

Gilead Sciences, after paying $10.8 billion for the developer of an experimental(Of a drug) Not licensed for use in humans, or as a treatment for a particular condition. Experimental drugs are studied in clinical trials to determine their safety and efficacy, and are sometimes made available via Special Access Schemes prior to their approval. hepatitis C drug, will soon give investors a better sense of whether its largest-deal ever is going to pay off.

GS-7977 Pharmasset Gilead HCV treatments HCV

Science & Medicine

Genetic testing for drug intolerance

The Guardian (UK), 15 Apr

Testing could prove an effective remedy to a widespread problem. But there may be hidden hazards to our privacy.

drug development pharmacogenetics abacavir privacy genetic-testing

Society & Culture

How To Deal With Death Online The Right Way

Gizmodo (US), 14 Apr

Your friends and family are going to die. Probably later, but maybe sooner. That much is certain. Another certainty is that, when it happens, we’ll all still be using some form of social media. Here’s how to grieve digitally, with dignity.

grief and loss social networking

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

This newsletter was first published on 16 April 2012 — more than one year ago.

Subscribe to this newsletter.

While the content of this newsletter was checked for accuracy at the time of publication, NAPWHA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

HIV Clinical Trials update